Genetic Counseling for TP53 Germline Mutations

作者: Maria Isabel Waddington Achatz , Patricia Ashton-Prolla

DOI: 10.1007/978-1-4614-3676-8_18

关键词:

摘要: Li–Fraumeni syndrome (LFS; OMIM # 151623) is an autosomal dominant disorder associated with multiple early-onset cancers. Classic LFS and its variants, collectively named Li–Fraumeni-like (LFL) syndrome, are two recognized forms of the syndrome. It estimated that carriers a germlineTP53 mutation have, on average, 50 % risk to develop cancer before age 40 years life 90 %. Clinical management individuals LFS/LFL major challenge due wide tumor spectrum. Monitoring strategies have shown reduce mortality in TP53 germline mutations. Cancer-prone families Southeastern Brazil been identified carry founder (c.1010G>A, p.R337H) at unusually high prevalence about 1:300 subjects (0.3 %). Structural functional studies p.R337H mutant proteins vitro pH-dependent defect oligomerization domain, making them inactive only conditions increased intracellular pH. The allele unique example pathogenic persisting among large mixed population. Genetic counseling should integrate clinical assessment care all carrying complexity diagnosis prognostic definitions, as well long-term impact being diagnosed their relatives, calls for multidisciplinary approach counseling, involving health professionals from areas expertise.

参考文章(86)
Susan Thomas Vadaparampil, Cheryl A. Miree, Crystal Wilson, Paul. B. Jacobsen, Psychosocial and Behavioral Impact of Genetic Counseling and Testing Breast Disease. ,vol. 27, pp. 97- 108 ,(2007) , 10.3233/BD-2007-27106
KA Metcalfe, A Liede, M Trinkaus, D Hanna, SA Narod, Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2. Clinical Genetics. ,vol. 62, pp. 464- 469 ,(2002) , 10.1034/J.1399-0004.2002.620607.X
Edward D. Lustbader, Sara Strom, Melissa L. Bondy, Louise C. Strong, Wick R. Williams, Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. American Journal of Human Genetics. ,vol. 51, pp. 344- 356 ,(1992)
Mauro F. Santibáñez-Koref, Karen J. Tricker, Alison Condie, Derek Crowther, Jillian M. Birch, D. Gareth R. Evans, Ann L. Hartley, Jane Prosser, Alan W. Craft, Eileen Thompson, John Martin, Martin Harris, Patricia H. Morris Jones, Osborne B. Eden, Aine Binchy, Anna M. Kelsey, Jillian R. Mann, Erika L. D. Mitchell, Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Research. ,vol. 54, pp. 1298- 1304 ,(1994)
Eeles Ra, Germline mutations in the TP53 gene. Cancer surveys. ,vol. 25, pp. 101- 124 ,(1995)
David E. Goldgar, Paul Kleihues, Rosalind A. Eeles, Nayanta Sodha, Hiroko Ohgaki, Pierre Hainaut, Magali Olivier, Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Research. ,vol. 63, pp. 6643- 6650 ,(2003)
Joseph F. Fraumeni, Frederick P. Li, Judy E. Garber, Kim E. Nichols, David Malkin, Germ-line p53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers Cancer Epidemiology, Biomarkers & Prevention. ,vol. 10, pp. 83- 87 ,(2001)
Kenneth Offit, Michal Sagi, Karen Hurley, Preimplantation Genetic Diagnosis for Cancer Syndromes JAMA. ,vol. 296, pp. 2727- 2730 ,(2006) , 10.1001/JAMA.296.22.2727
Enrico L. DiGiammarino, Amanda S. Lee, Craig Cadwell, Weixing Zhang, Brian Bothner, Raul C. Ribeiro, Gerard Zambetti, Richard W. Kriwacki, A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer Nature Structural & Molecular Biology. ,vol. 9, pp. 12- 16 ,(2002) , 10.1038/NSB730